{"lastClose": 1.2000000476837158, "len": 478, "date": "2023-02-09", "alpha_1": -0.9145060369398873, "beta_1": 0.19896279029245076, "drawup_1": 0.7325581218050006, "natr_1": 30.396197585326306, "sup_1": -0.06555560301851161, "res_1": 0.22638879644650356, "bullPattern_1": [], "bearPattern_1": ["BELTHOLD", "COUNTERATTACK", "LONGLINE"], "rsi_1": 66.1290308108485, "adx_1": 44.97808296290735, "drawdown_1": -0.9065934078890032, "stratHoldSharpe_1": -1.8350145290053261, "stratHoldAlpha_1": 249.72940837995387, "stratHoldDrawdown_1": -0.816921560138098, "alpha_3mo": -0.6780187713921358, "beta_3mo": -0.407229913633691, "drawup_3mo": 0.4117647223819081, "natr_3mo": 30.396197585326306, "sup_3mo": -0.003889004234909843, "res_3mo": 0.05666653090053674, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 85.87961359658333, "adx_3mo": 87.70276407524024, "drawdown_3mo": -0.4295301889923263, "stratHoldSharpe_3mo": 0.8165925610879726, "stratHoldAlpha_3mo": 251.56143466901744, "stratHoldDrawdown_3mo": -0.3969675966724687, "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Market Cap": 303239576, "Sector": "Health Care", "Name": "LumiraDx Limited", "Country": "Cayman Islands", "alpha%_1": 0.004018580463107282, "beta%_1": 0.06273931433616833, "drawup%_1": 0.6909328783288008, "natr%_1": 1.0, "drawdown%_1": 0.004544397006908767, "stratHoldSharpe%_1": 0.0037833233736980585, "stratHoldAlpha%_1": 1.9740718974477411e-07, "stratHoldDrawdown%_1": 0.005352260129279918, "alpha%_3mo": 0.0848714928212474, "beta%_3mo": 0.008717500633372134, "drawup%_3mo": 0.8199485486279543, "natr%_3mo": 1.0, "drawdown%_3mo": 0.0008773143961925647, "stratHoldSharpe%_3mo": 0.4677167201853863, "stratHoldAlpha%_3mo": 0.7143231618907419, "stratHoldDrawdown%_3mo": 0.0006461834798156225}